PubRank
Search
About
Ulf Stenestrand
Author PubWeight™ 47.22
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
N Engl J Med
2007
4.95
2
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.
Eur Heart J
2009
2.68
3
The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).
Heart
2010
2.24
4
Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission.
Heart
2007
2.05
5
Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
Circulation
2009
1.93
6
Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease.
Circulation
2011
1.85
7
Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction.
Eur Heart J
2006
1.70
8
Digoxin and mortality in atrial fibrillation: a prospective cohort study.
Eur J Clin Pharmacol
2007
1.66
9
Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.
BMJ
2010
1.65
10
Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Arch Intern Med
2010
1.57
11
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
J Am Coll Cardiol
2010
1.44
12
Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction.
Kidney Int
2011
1.43
13
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.
Eur Heart J
2003
1.41
14
Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
N Engl J Med
2009
1.41
15
The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination.
JACC Cardiovasc Interv
2011
1.38
16
Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
Circ Cardiovasc Interv
2009
1.25
17
Gender differences in management and outcome in non-ST-elevation acute coronary syndrome.
Heart
2006
1.22
18
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.
Am J Cardiol
2010
1.20
19
Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction.
Heart
2010
1.00
20
Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART).
Am Heart J
2010
0.97
21
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
J Am Coll Cardiol
2009
0.96
22
How to set up an effective national primary angioplasty network: lessons learned from five European countries.
EuroIntervention
2009
0.96
23
Daylight saving time shifts and incidence of acute myocardial infarction--Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Sleep Med
2012
0.94
24
Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial.
Am Heart J
2004
0.91
25
Gender difference in prevalence and prognostic impact of renal insufficiency in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Heart
2011
0.90
26
Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria.
J Am Coll Cardiol
2009
0.86
27
The effect of early mobilisation for patient undergoing coronary angiography; a pilot study with focus on vascular complications and back pain.
Eur J Cardiovasc Nurs
2010
0.85
28
Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery.
Eur Heart J
2007
0.83
29
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
Clin Ther
2005
0.82
30
Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment.
J Am Coll Cardiol
2010
0.81
31
Large differences between patients with acute myocardial infarction included in two Swedish health registers.
Scand J Public Health
2013
0.80
32
Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
EuroIntervention
2011
0.79
33
Although women are less likely to be admitted to coronary care units, they are treated equally to men and have better outcome. A prospective cohort study in patients with non ST-elevation acute coronary syndromes.
Acute Card Care
2009
0.78
34
Influence of left bundle branch block on long-term mortality in a population with heart failure.
Eur Heart J
2007
0.77
35
Early treatment with abciximab in patients with ST elevation myocardial infarction results in a high rate of normal or near normal blood flow in the infarct related artery.
Acute Card Care
2010
0.77
36
Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA.
Heart
2010
0.75
37
Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI.
J Electrocardiol
2005
0.75